197 related articles for article (PubMed ID: 33826027)
21. Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer: A real-world, multicenter, retrospective, controlled study in China.
Chen H; Ma X; Liu J; Yang Y; Fang Y; Wang L; Fang J; Zhao J; Zhuo M
Chin J Cancer Res; 2022 Aug; 34(4):353-364. PubMed ID: 36199537
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
Langer CJ; Albert I; Ross HJ; Kovacs P; Blakely LJ; Pajkos G; Somfay A; Zatloukal P; Kazarnowicz A; Moezi MM; Schreeder MT; Schnyder J; Ao-Baslock A; Pathak AK; Berger MS;
Lung Cancer; 2014 Sep; 85(3):420-8. PubMed ID: 24997137
[TBL] [Abstract][Full Text] [Related]
23. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.
Zhou T; Zhang Z; Luo F; Zhao Y; Hou X; Liu T; Wang K; Zhao H; Huang Y; Zhang L
JAMA Netw Open; 2020 Oct; 3(10):e2015748. PubMed ID: 33074323
[TBL] [Abstract][Full Text] [Related]
24. Combination of the EP and Anti-PD-1 Pathway or Anti-CTLA-4 for the Phase III Trial of Small-Cell Lung Cancer: A Meta-Analysis.
Abunasser AAA; Xue J; Balawi EJA; Zhu Y
J Oncol; 2021; 2021():6662344. PubMed ID: 34122547
[TBL] [Abstract][Full Text] [Related]
25. Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.
Reck M; Luft A; Szczesna A; Havel L; Kim SW; Akerley W; Pietanza MC; Wu YL; Zielinski C; Thomas M; Felip E; Gold K; Horn L; Aerts J; Nakagawa K; Lorigan P; Pieters A; Kong Sanchez T; Fairchild J; Spigel D
J Clin Oncol; 2016 Nov; 34(31):3740-3748. PubMed ID: 27458307
[TBL] [Abstract][Full Text] [Related]
26. Thoracic radiotherapy may improve the outcome of extensive stage small cell lung carcinoma patients treated with first-line immunotherapy plus chemotherapy.
Wu JJ; Huang JW; Hsu KH; Huang YH; Chen KC; Tseng JS; Yang TY; Chang GC
Anticancer Drugs; 2022 Nov; 33(10):e842-e849. PubMed ID: 36206101
[TBL] [Abstract][Full Text] [Related]
27. Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial.
Oh IJ; Kim KS; Park CK; Kim YC; Lee KH; Jeong JH; Kim SY; Lee JE; Shin KC; Jang TW; Lee HK; Lee KY; Lee SY
BMC Cancer; 2016 Aug; 16(1):690. PubMed ID: 27566413
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen.
Li L; Li Q; Xu Y; Huang M; Liu Y; Gong Y; Peng F; Zhou L; Ding Z; Ren L; Wang J; Lu Y; Zhu J; Hou M
Thorac Cancer; 2013 Aug; 4(3):234-240. PubMed ID: 28920253
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer.
Ding D; Hu H; Li S; Zhu Y; Shi Y; Liao M; Liu J; Tian X; Liu A; Huang J
J Natl Compr Canc Netw; 2021 Aug; 19(10):1141-1147. PubMed ID: 34348237
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901.
Morikawa N; Inoue A; Sugawara S; Maemondo M; Harada T; Harada M; Fujita Y; Katoh T; Yokouchi H; Watanabe H; Usui K; Suzuki T; Sakakibara-Konishi J; Nagai H; Kanbe M; Nukiwa T
Lung Cancer; 2017 Sep; 111():38-42. PubMed ID: 28838395
[TBL] [Abstract][Full Text] [Related]
31. Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.
Kim HR; Awad MM; Navarro A; Gottfried M; Peters S; Csőszi T; Cheema PK; Rodriguez-Abreu D; Wollner M; Yang JC; Mazieres J; Orlandi FJ; Luft A; Gümüş M; Kato T; Kalemkerian GP; Luo Y; Santorelli ML; Pietanza MC; Rudin CM
JTO Clin Res Rep; 2023 Nov; 4(11):100572. PubMed ID: 37954964
[TBL] [Abstract][Full Text] [Related]
32. Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.
Ando K; Manabe R; Kishino Y; Kusumoto S; Yamaoka T; Tanaka A; Ohmori T; Ohnishi T; Sagara H
Curr Oncol; 2021 Feb; 28(2):1094-1113. PubMed ID: 33673470
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Tanaka H; Tanzawa S; Misumi T; Makiguchi T; Inaba M; Honda T; Nakamura J; Inoue K; Kishikawa T; Nakashima M; Fujiwara K; Kohyama T; Ishida H; Kuyama S; Miyazawa N; Nakamura T; Miyawaki H; Oda N; Ishikawa N; Morinaga R; Kusaka K; Fujimoto N; Fukuda Y; Yasugi M; Tsuda T; Ushijima S; Shibata K; Shibayama T; Bessho A; Kaira K; Shiraishi K; Matsutani N; Seki N
Ther Adv Med Oncol; 2022; 14():17588359221142786. PubMed ID: 36570411
[TBL] [Abstract][Full Text] [Related]
34. A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Mavroudis D; Papadakis E; Veslemes M; Tsiafaki X; Stavrakakis J; Kouroussis C; Kakolyris S; Bania E; Jordanoglou J; Agelidou M; Vlachonicolis J; Georgoulias V;
Ann Oncol; 2001 Apr; 12(4):463-70. PubMed ID: 11398877
[TBL] [Abstract][Full Text] [Related]
35. The benefits of etoposide capsules as maintenance therapy for patients with extensive-stage small cell lung cancer: a prospective two-stage, two-center study.
Zhang C; Duan J; He Z; Yang L; Yang S; Zhang Z; Liu Y; Wan R; Lin L; Wu X; Wang W; Wang Q; Wang J
J Thorac Dis; 2021 Jan; 13(1):343-352. PubMed ID: 33569214
[TBL] [Abstract][Full Text] [Related]
36. Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer.
Xiao X; Wang S; Xia S; Zou M; Li Y; Wei Y; Mei Q; Chen Y
Onco Targets Ther; 2015; 8():2209-14. PubMed ID: 26345293
[TBL] [Abstract][Full Text] [Related]
37. Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer.
Moro-Sibilot D; Falchero L; Ardin C; Zouak A; Molinier O; Romand P; Leleu O; Amrane K; Berndt C; Langlais A; Morin F; Westeel V
Respir Med Res; 2024 Apr; 86():101113. PubMed ID: 38843598
[TBL] [Abstract][Full Text] [Related]
38. The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study.
Zheng HR; Jiang AM; Gao H; Liu N; Zheng XQ; Fu X; Ruan ZP; Tian T; Liang X; Yao Y
Front Oncol; 2022; 12():894835. PubMed ID: 36203439
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.
Li YY; Zhou C; Yang DX; Wang J; Liu ZJ; Wang XY; Li K
Cancer Biol Med; 2015 Jun; 12(2):117-25. PubMed ID: 26175927
[TBL] [Abstract][Full Text] [Related]
40. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T; van der Heijden MS; Castellano D; Galsky MD; Loriot Y; Petrylak DP; Ogawa O; Park SH; Lee JL; De Giorgi U; Bögemann M; Bamias A; Eigl BJ; Gurney H; Mukherjee SD; Fradet Y; Skoneczna I; Tsiatas M; Novikov A; Suárez C; Fay AP; Duran I; Necchi A; Wildsmith S; He P; Angra N; Gupta AK; Levin W; Bellmunt J;
Lancet Oncol; 2020 Dec; 21(12):1574-1588. PubMed ID: 32971005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
